It’s a serious heart defect that can cause blood to flow into the wrong part of the heart chamber, and up until recently, it ...
(HealthDay News) — Severe valvular heart disease (VHD) is prevalent among patients with cancer and is associated with reduced survival, according to a study presented at the annual congress of the ...
Objectives Older adults can have difficulties understanding and recalling information prior to hospitalisation for elective treatment. Limited research exists regarding how older adults perceive the ...
A family from Westport has been connected with IU for years. Instead of a check-up on his heart, 10-year-old Drew Shouse was ...
The Sapien M3 transcatheter mitral valve replacement system won FDA approval -- making it the first on the market to utilize ...
Edwards Lifesciences stock is supported by its growth outlook and the impact of clinical advances. See why investors should ...
Routine echocardiography in cancer centers can spot severe valve disease earlier and trigger timely treatment decisions.
A large study revealed that severe valvular heart disease is common among cancer patients and is associated with poorer ...
Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...
Background The natural history of asymptomatic moderate or severe aortic regurgitation (AR) remains uncertain, with conflicting reports about its progression and surgical timing. We aimed to quantify ...
Hosted on MSN
Edwards Lifesciences’ SAPIEN X4 Study: A Potential Game-Changer in Heart Valve Treatment
Edwards Lifesciences Corp. ((EW)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results